These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31851572)

  • 1. HLA-A26 is a risk factor for Behçet's disease ocular lesions.
    Kato H; Takeuchi M; Horita N; Ishido T; Mizuki R; Kawagoe T; Shibuya E; Yuda K; Ishido M; Mizuki Y; Hayashi T; Meguro A; Kirino Y; Minegishi K; Nakano H; Yoshimi R; Kurosawa M; Fukumoto T; Takeno M; Hotta K; Kaneko T; Mizuki N
    Mod Rheumatol; 2021 Jan; 31(1):214-218. PubMed ID: 31851572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant association of HLA-A26 with uveitis and gastrointestinal involvement in patients with Behçet's disease in a multicentre study.
    Nakajima T; Tsuji H; Inaba R; Saito R; Nishimura K; Morinobu A
    Mod Rheumatol; 2024 Oct; 34(6):1221-1225. PubMed ID: 38482606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.
    Mizuki Y; Horita N; Horie Y; Takeuchi M; Ishido T; Mizuki R; Kawagoe T; Shibuya E; Yuda K; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Fukumoto T; Kurosawa M; Kitaichi N; Takeno M; Kaneko T; Mizuki N
    Mod Rheumatol; 2020 Jul; 30(4):708-714. PubMed ID: 31386589
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.
    Ishido T; Horita N; Takeuchi M; Kawagoe T; Shibuya E; Yamane T; Hayashi T; Meguro A; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Ishigatsubo Y; Takeno M; Kurosawa M; Kaneko T; Mizuki N
    Rheumatology (Oxford); 2017 Nov; 56(11):1918-1927. PubMed ID: 28968732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the major histocompatibility complex and clinical response to infliximab therapy in patients with Behçet uveitis.
    Kuroyanagi K; Sakai T; Kohno H; Okano K; Akiyama G; Aoyagi R; Inaba M; Tsuneoka H
    Jpn J Ophthalmol; 2015 Nov; 59(6):401-8. PubMed ID: 26318435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
    Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
    Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and non-genetic factors affecting the visual outcome of ocular Behcet's disease.
    Kang EH; Park JW; Park C; Yu HG; Lee EB; Park MH; Song YW
    Hum Immunol; 2013 Oct; 74(10):1363-7. PubMed ID: 23831258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-B51 Impact on Clinical Symptoms in Behcet's Disease.
    Pamukcu M; Duran TI; Demirag MD
    J Coll Physicians Surg Pak; 2022 Jul; 32(7):904-908. PubMed ID: 35795941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single center study on ethnic and clinical features of Behcet's disease in Moscow, Russia.
    Lennikov A; Alekberova Z; Goloeva R; Kitaichi N; Denisov L; Namba K; Takeno M; Ishigatsubo Y; Mizuki N; Nasonov E; Ishida S; Ohno S
    Clin Rheumatol; 2015 Feb; 34(2):321-7. PubMed ID: 24322831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B51 subtypes in Turkish patients with Behçet's disease and their correlation with clinical manifestations.
    Demirseren DD; Ceylan GG; Akoglu G; Emre S; Erten S; Arman A; Metin A
    Genet Mol Res; 2014 Jul; 13(3):4788-96. PubMed ID: 25062414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite polymorphisms of the MICA gene among Japanese patients with Behçet's disease.
    Nishiyama M; Takahashi M; Manaka K; Suzuki S; Saito M; Nakae K
    Can J Ophthalmol; 2006 Apr; 41(2):210-5. PubMed ID: 16767211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behçet's disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I.
    Kuranov AB; Kötter I; Henes JC; Abisheva ST; Steiert I; Riewerts F; Momynaliev KT; Müller CA
    Arthritis Res Ther; 2014 May; 16(3):R116. PubMed ID: 24887019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of familial occurrence of Behçet's disease with and without ocular lesions.
    Nishiyama M; Nakae K; Umehara T
    Jpn J Ophthalmol; 2001; 45(3):313-6. PubMed ID: 11369384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behçet's disease.
    Suwa A; Horita N; Ishido T; Takeuchi M; Kawagoe T; Shibuya E; Yamane T; Hayashi T; Meguro A; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Fukumoto T; Ishigatsubo Y; Kurosawa M; Kaneko T; Takeno M; Mizuki N
    Mod Rheumatol; 2019 Mar; 29(2):357-362. PubMed ID: 29583036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease.
    Verity DH; Wallace GR; Vaughan RW; Kondeatis E; Madanat W; Zureikat H; Fayyad F; Marr JE; Kanawati CA; Stanford MR
    Tissue Antigens; 1999 Sep; 54(3):264-72. PubMed ID: 10519363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the major histocompatibility complex locus association with Behçet's disease in Iran.
    Xavier JM; Davatchi F; Abade O; Shahram F; Francisco V; Abdollahi BS; Trindade H; Nadji A; Shafiee NM; Ghaderibarmi F; Ligeiro D; Oliveira SA
    Arthritis Res Ther; 2015 Mar; 17(1):81. PubMed ID: 25889189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.
    Takeuchi M; Ombrello MJ; Kirino Y; Erer B; Tugal-Tutkun I; Seyahi E; Özyazgan Y; Watts NR; Gül A; Kastner DL; Remmers EF
    Ann Rheum Dis; 2016 Dec; 75(12):2208-2211. PubMed ID: 27217550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients.
    Hamzaoui A; Houman MH; Massouadia M; Ben Salem T; Khanfir MS; Ben Ghorbel I; Miled M
    Eur J Intern Med; 2012 Jun; 23(4):347-9. PubMed ID: 22560383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.
    Maldini C; Lavalley MP; Cheminant M; de Menthon M; Mahr A
    Rheumatology (Oxford); 2012 May; 51(5):887-900. PubMed ID: 22240504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of HLA-B*51:01 and -A*26:01 to Behçet's disease and their clinical association in Thai patients.
    Louthrenoo W; Kasitanon N; Pathanapitoon K; Wangkaew S; Kuwata S; Nishi A; Kaburaki T; Tanaka R; Takeuchi F
    Int J Rheum Dis; 2020 Feb; 23(2):247-255. PubMed ID: 31944588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.